4th Quarter - Report
STANTON PARK GROUP for VERTEX PHARMACEUTICALS INCORPORATED
Firm
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Raising awareness of Hepatitis C (no specific bills); Access to rare and orphan disease therapeutics under the enactment of ACA (no specific bills); FDA regulatory pathways for pharmaceuticals (no specific bills); H.R. 460 The Patients' Access to Treatments Act of 2013 (all provisions). Awareness of Cystic Fibrosis (no specific bills)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES DERDERIAN | — |
| VALERIE HENRY | — |
| PATRICK LYDEN | — |
| RICHARD MATHER RUSSELL | — |
| ERIN STRAWN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.